The rising cancer trend that requires adjusting workplace support
Cancer incidence among under-50s has risen by 79% since 1990. For employers, that is not just a health statistic; it is a workforce reality. More people are being diagnosed while still building careers, paying mortgages, raising families and relying on work for income, identity and routine.
Many workplace health and wellbeing programmes were designed around the assumption that cancer is more likely to arrive later in life. The test now is whether those programmes work as well for someone diagnosed at 34 as they do for someone diagnosed at 64.
Benefits aimed at an older workforce
Policies should explicitly cover cancer and other chronic illnesses, including the financial impact of diagnosis. Younger employees may have less savings, higher housing costs or childcare commitments, so employers should check whether income protection, critical illness cover and financial guidance are visible, accessible and fit for purpose.
Screening and education also need attention. National screening only covers some cancers and is shaped by age thresholds, leaving many employees in their thirties or forties outside routine checks. Employers cannot diagnose, but they can share clear information on symptoms, prevention and when to seek medical advice.
Earlier diagnosis is better for the employee and less costly for the employer. In fact, late stage cancer diagnosis costs 112% more than early-stage diagnosis.
Recovery rarely follows the plan it was given
Cancer care is often fragmented, in the private sector as well as the NHS, and much of the coordination falls to the patient. Chasing results, arranging appointments and navigating treatment can become a second job when someone has least capacity for it.
More people are living with cancer for years, often managing fatigue, cognitive changes or long-term side effects. Return to work is rarely a single event, so support needs to flex over time rather than ending once treatment does.
Clear adjustment policies are essential. Employees and line managers should know what support exists, how to access it and that using it will not prejudice the employee’s role or career. Adjustments also need regular review as needs change.
Career and money worries do not wait for treatment to finish
For someone earlier in their career, even with legal protections under the Equality Act, diagnosis can raise difficult questions about progression, workload and long-term security. Financial pressure can compound this for employees with limited savings or family responsibilities.
Career guidance, financial advice and carer support should therefore be part of cancer support, not an optional extra. The employee caring for a partner or parent may be carrying a similar load and is often less visible to the organisation.
None of it works without the manager
Managers are often unsure what to say, whether to raise the conversation directly or wait to be told. Training on sensitive conversations, confidentiality, team communication and keeping development live can make the difference between policy that exists and support that is actually felt.
Without that training, responsibility falls back on the person recovering, who must manage benefits, adjustments and explanations while also managing their health.
The rise in cancer among under-50s is not a temporary blip. It cuts across benefits, screening, recovery, careers and management as one connected challenge. Employers that review the whole journey with a younger workforce in mind, and ask whether their support would work for a 34-year-old, will be better prepared for the workforce they already have.
Practical support across the cancer journey
For employers looking to move from policy to practical, personalised support, Healix Health’s Cancer Care Performance Pathway connects prevention, early detection, nurse-led navigation, treatment support and return-to-work planning across the full cancer journey. Find out more about the Cancer Care Performance Pathway here.
Supplied by REBA Associate Member, Healix Health
The UK's leading independent corporate healthcare trust provider.
